6.48 USD
↗ 0.46 (7.64%)AT CLOSE (11:59 AM EDT)
Cybin Inc. Common Stock
HELPNASDAQ • USD
6.45
↘ 0.04 (0.54%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
6.45
↘ 0.04 (0.54%)
Market: CLOSED
Shares of Cybin Inc. Common Stock (HELP) are trading at $6.48. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$5.90
High?$6.60
Low?$5.88
Prev. Close?$6.02
Volume?2.9M
Avg. Volume?N/A
VWAP?$6.37
Bid / Ask
Bid?$5.52 × 100
Ask?$7.20 × 600
Spread?$1.68
Midpoint?$6.36
Valuation & Ratios
Market Cap?300.4M
Shares Out?51.6M
Float?50.1M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?6.21%Elevated
Short Interest?3.1M
Days to Cover?5.2
Free Float50.1M
Avg Daily Volume596.6K
Settlement Date2026-06-15